President Joe Biden's $3 billion pandemic rescue package includes $80 million in funding for to strengthen the US's public health IT and data science capabilities.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh